We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-1.55%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$41.7B
AUM Growth
+$2.19B
Cap. Flow
+$591M
Cap. Flow %
1.42%
Top 10 Hldgs %
9.51%
Holding
3,328
New
131
Increased
1,345
Reduced
1,491
Closed
336
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YOKU
1401
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
$3.37M 0.01%
187,811
+15,304
+9% +$308K
BXMT icon
1402
Blackstone Mortgage Trust
BXMT
$2.35B
$3.36M 0.01%
124,104
-44,800
-27% -$1.28M
FLO icon
1403
Flowers Foods
FLO
$1.57B
$3.36M 0.01%
183,030
+24,729
+16% +$483K
UL icon
1404
Unilever
UL
$139B
$3.35M 0.01%
71,196
-225,338
-76% -$11.1M
INSY
1405
DELISTED
Insys Therapeutics, Inc.
INSY
$3.35M 0.01%
172,684
-23,596
-12% -$371K
MAIN icon
1406
Main Street Capital
MAIN
$5.22B
$3.35M 0.01%
109,240
+32,974
+43% +$1.05M
VRN
1407
DELISTED
Veren
VRN
$3.35M 0.01%
100,246
+78,071
+352% +$2.88M
MUE
1408
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
$3.34M 0.01%
251,151
+41,472
+20% +$542K
WLK icon
1409
Westlake Corp
WLK
$10.1B
$3.33M 0.01%
38,505
-13,425
-26% -$1.21M
TM icon
1410
Toyota
TM
$220B
$3.33M 0.01%
28,312
+13,912
+97% +$1.64M
SWC
1411
DELISTED
Stillwater Mining Co
SWC
$3.32M 0.01%
221,053
+6,491
+3% +$116K
XLS
1412
DELISTED
EXELIS INC COM STK
XLS
$3.31M 0.01%
200,285
-52,263
-21% -$849K
HTGC icon
1413
Hercules Capital
HTGC
$3.12B
$3.31M 0.01%
228,700
-219,659
-49% -$3.48M
BIG
1414
DELISTED
Big Lots, Inc.
BIG
$3.31M 0.01%
76,812
-5,645
-7% -$257K
CLDX icon
1415
Celldex Therapeutics
CLDX
$3.22B
$3.29M 0.01%
16,896
+2,525
+18% +$550K
BSJJ
1416
DELISTED
Invesco BulletShares 2019 High Yield Corporate Bond ETF
BSJJ
$3.28M 0.01%
127,750
+103,138
+419% +$2.7M
OCSL icon
1417
Oaktree Specialty Lending
OCSL
$1.06B
$3.28M 0.01%
119,138
-165,473
-58% -$4.83M
DE icon
1418
CALL
Deere & Co
DE
$165B
$3.28M 0.01%
+40,000
New +$3.42M
CAR icon
1419
Avis
CAR
$4.9B
$3.27M 0.01%
59,642
-6,075
-9% -$380K
PRXL
1420
DELISTED
Parexel International Corp
PRXL
$3.27M 0.01%
51,868
+37,457
+260% +$2.13M
CCEC
1421
Capital Clean Energy Carriers
CCEC
$1.37B
$3.26M 0.01%
46,664
-2,758
-6% -$208K
ISEE
1422
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$3.26M 0.01%
83,715
+54,687
+188% +$2.15M
CNK icon
1423
Cinemark Holdings
CNK
$4.38B
$3.26M 0.01%
95,647
-156,365
-62% -$5.43M
NKTR icon
1424
Nektar Therapeutics
NKTR
$2.47B
$3.25M 0.01%
17,959
-334
-2% -$63.9K
NNP
1425
DELISTED
NUVEEN NY PERF PLUS MUNI FD
NNP
$3.24M 0.01%
232,678
+2,612
+1% +$36.7K

Similar funds

Guggenheim Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Guggenheim Capital held 3,328 positions worth $41.7B, up 5.5% from $39.5B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Guggenheim Capital's Q3 2014 filing shows 131 new, 1,345 increased, 1,491 reduced and 336 closed positions. Its largest new stake was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M. The largest sale was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, an estimated $98.4M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Guggenheim Capital's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M.
  • Guggenheim Capital added most to CLAYMORE GUGGENHEIM BULLETSHARES 2015 CORP BD ETF in Q3 2014, an estimated $96.3M increase.
  • Guggenheim Capital's biggest Q3 2014 reduction was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, cutting an estimated $98.4M.
  • Guggenheim Capital fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $40.1M.
  • Guggenheim Capital's ten largest holdings make up 9.5% of its $41.7B portfolio in Q3 2014.
  • Guggenheim Capital opened 131 new positions and closed 336 in Q3 2014.
  • Guggenheim Capital's portfolio value rose 5.5% quarter-over-quarter to $41.7B.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.